Recent Company News

• 04:58 PM ET Mar 28, 2026
  

  Amgen announces Repatha cuts risk of first major cardiovascular events by 31% in high-risk patients without known significant atherosclerosis ($348.77, 0.00)

• 01:08 AM ET Mar 09, 2026
  

  Aspen Pharmacare Holdings upgraded to buy from hold at HSBC (ZAR 138.03, 0.00)

• 02:30 AM ET Mar 04, 2026
  

  Transcript Intelligence: Aspen Pharmacare Holdings Q2 Earnings Guidance

• 02:30 AM ET Mar 04, 2026
  

  Transcript Intelligence: Aspen Pharmacare Holdings Q2 Earnings Themes

• 02:30 AM ET Mar 04, 2026
  

  Transcript Intelligence: Aspen Pharmacare Holdings Q2 Earnings Q&A

• 06:11 AM ET Mar 03, 2026
  

  Aspen Pharmacare Holdings reports H1 HEPS 417.4c vs guidance 400.1-432.4c (ZAR 133.12, -1.28)

• 09:49 AM ET Feb 11, 2026
  

  Aspen Pharmacare Holdings expects H1 normalised headline EPS in range of 400.1 to 432.4 vs year-ago 645.4 (ZAR 109.67, +0.42)

• 09:13 AM ET Jan 15, 2026
  

  Transcript Intelligence: Aspen Pharmacare Holdings Aspen APAC Divestment Call (ZAR124.28, +0.94)

• 02:46 AM ET Jan 13, 2026
  

  Aspen Pharmacare Holdings to host live webcast on 15-Jan in connection with previously announced sale of Aspen APAC (ZAR 117.65, -0.79)

• 10:46 AM ET Jan 05, 2026
  

  StreetAccount M&A Summary: Week of 29-Dec